Related Experiment Video
Updated: Jul 2, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Arterial function and intima-media thickness in hypertensive patients with erectile dysfunction
Charalambos Vlachopoulos1, Konstantinos Aznaouridis, Nikolaos Ioakeimidis
1Cardiovascular Diseases and Sexual Health Unit and Hypertension Unit, 1st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece. cvlachop@otenet.gr
Insights
Erectile dysfunction in hypertensive men is linked to arterial issues and inflammation, indicating subclinical atherosclerosis. The severity of erectile dysfunction did not correlate with these arterial markers.
Area of Science:
- Cardiovascular Medicine
- Urology
- Vascular Biology
Background:
- Erectile dysfunction (ED) is a significant predictor of cardiovascular risk, particularly prevalent in hypertensive individuals.
- Hypertension is a major risk factor for endothelial dysfunction and atherosclerosis.
Purpose of the Study:
- To investigate the relationship between erectile dysfunction and arterial structure/function in hypertensive patients.
- To assess arterial characteristics and systemic inflammatory markers in hypertensive men with and without ED.
Main Methods:
- Cross-sectional study comparing 52 hypertensive men with vasculogenic ED to 34 hypertensive men with normal erectile function.
- Evaluation of arterial structure (common carotid intima-media thickness) and function (carotid-femoral pulse-wave velocity, flow-mediated dilation).
- Measurement of systemic markers of endothelial dysfunction (asymmetric dimethylarginine) and inflammation (high-sensitivity C-reactive protein, interleukin-6).
Main Results:
- Hypertensive men with ED exhibited increased common carotid intima-media thickness and carotid-femoral pulse-wave velocity.
- Lower flow-mediated dilation of the brachial artery and elevated levels of asymmetric dimethylarginine, high-sensitivity C-reactive protein, and interleukin-6 were observed in the ED group.
- Multivariable analysis confirmed independent associations between ED and impaired arterial structure and function, independent of other risk factors.
Conclusions:
- The presence of vasculogenic erectile dysfunction in hypertensive men is associated with subclinical atherosclerosis.
- Impaired arterial function, endothelial dysfunction, and systemic inflammatory activation are linked to erectile dysfunction in this population.
- The severity of erectile dysfunction did not correlate with the measured arterial indices or inflammatory markers.
Objective:
Erectile dysfunction is a predictor of cardiovascular risk with high prevalence in hypertensive men. We investigated whether erectile dysfunction is related to arterial structure and function in hypertensive patients.
Methods:
We evaluated arterial structural and functional characteristics and measured systemic endothelial/inflammatory markers in 52 hypertensive men with vasculogenic erectile dysfunction and in 34 hypertensive men with normal erectile function, matched for age, blood pressure, risk factors and treatment.
Results:
Hypertensive patients with erectile dysfunction had higher common carotid intima-media thickness (0.95 +/- 0.19 vs. 0.83 +/- 0.18 mm, P = 0.003) and carotid-femoral pulse-wave velocity (8.89 +/- 1.38 vs. 8.11 +/- 1.10 m/s, P = 0.007), lower flow-mediated dilation of the brachial artery (absolute values of 2.96 +/- 1.64 vs. 4.07 +/- 1.68%, P = 0.003) and a higher level of the systemic endothelial dysfunction marker asymmetric dimethylarginine (0.67 +/- 0.13 vs. 0.57 +/- 0.16 mumol/l, P = 0.003), and the inflammatory markers high-sensitivity C-reactive protein [2.03 (1.16-2.89) vs. 1.23 (0.67-1.90) mg/l, P = 0.029] and interleukin-6 (4.13 +/- 2.38 vs. 2.77 +/- 1.92 pg/ml, P = 0.011). Multivariable analysis adjusting for age, mean pressure, other risk factors and treatment showed independent associations between erectile dysfunction and parameters of arterial structure and function. In the erectile dysfunction group, there were no significant relationships between the severity of erectile dysfunction (as expressed by the Sexual Health Inventory for Men score) and the above arterial indices and level of circulating markers (all P = NS).
Conclusion:
In hypertensive men, the presence but not the severity of vasculogenic erectile dysfunction is associated with subclinical atherosclerosis, impairment of arterial function and systemic endothelial and inflammatory activation.
Related Concept Videos
Arteries and Arterioles
Hypertension II: Pathophysiology
Structure of Blood Vessels
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
